Sensus Healthcare, Inc. (SRTS)

Market Cap	116.37M
Revenue (ttm)	41.31M
Net Income (ttm)	9.31M
Shares Out	16.39M
EPS (ttm)	0.57
PE Ratio	12.48
Forward PE	14.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	216,239
Open	7.09
Previous Close	7.21
Day's Range	7.06 - 7.47
52-Week Range	2.15 - 9.33
Beta	1.18
Analysts	Strong Buy
Price Target	12.50 (+76.06%)
Earnings Date	Feb 6, 2025

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which pr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 3, 2016
• Employees: 35
• Stock Exchange: NASDAQ
• Ticker Symbol: SRTS
• Website: https://sensushealthcare.com

Financial Performance

In 2023, Sensus Healthcare's revenue was $24.41 million, a decrease of -45.20% compared to the previous year's $44.53 million. Earnings were $485,000, a decrease of -98.00%.

Analyst Forecast

According to 2 analysts, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $12.5, which is an increase of 76.06% from the latest price.

Price Target

$12.5

(76.06% upside)

Analyst Consensus: Strong Buy